Back to Rankings

CNSP

CNSF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-21
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
CNSP vs peer average
40/100
CNSP vs. peer average (F vs. D)
Grade spread
B 1 · D 2 · F 5
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RNAZ is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $7.98M

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerRNAZTransCode Therapeutics
CNSP
CNS
RNAZ
TransCode Therapeutics
Grade
F
F
Momentum
13
8
Value
41
58
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive

Grade position vs RNAZ

CNSP / RNAZ
Grade Position
Below peers
CNSP vs. peer average (F vs. D)
40/100
Momentum
13
CNSP
Value
41
RNAZ
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs CNSP
1
RNAZ
TransCode Therapeutics Inc Common
F
20/100
Even
2
BOLT
Bolt Biotherapeutics Inc Common
D
40/100
-1
3
LIMN
Liminatus Pharma Inc Class A Common
F
20/100
Even
4
APRE
Aprea Therapeutics Inc Common
F
20/100
Even
5
MTVA
MetaVia Inc Common
D
40/100
-1
RNAZ is the first peer returned for this comparison set.